Shushan Hovsepyan: Ian Tannock compared inhibiting tumor mutations to tree pruning

Shushan Hovsepyan, a Pediatric Oncologist and Clinical Research Coordinator at the Yeolyan Hematology and Oncology Center, shared on X:

“Precision Medicine?

Ian Tannock compared inhibiting tumor mutations to tree pruning: targeting some may not stop the growth, as other parts can still progress.
Despite identifiable genetic profiles being 80%, the response is 1%-30% with matched drugs.“

Read further.
Source: Shushan Hovsepyan/X